[HTML][HTML] Type I interferon signaling mediates Mycobacterium tuberculosis–induced macrophage death
L Zhang, X Jiang, D Pfau, Y Ling… - Journal of Experimental …, 2021 - rupress.org
Macrophages help defend the host against Mycobacterium tuberculosis (Mtb), the major
cause of tuberculosis (TB). Once phagocytized, Mtb resists killing by macrophages …
cause of tuberculosis (TB). Once phagocytized, Mtb resists killing by macrophages …
Progression of tuberculosis among patients with rheumatic diseases–A systematic review and meta-analysis
K Sundaram, LK Vajravelu, R Velayutham… - Indian Journal of …, 2023 - Elsevier
Background Tuberculosis is a contagious disease that ranks among the top ten killers of
humans worldwide. Mycobacterium tuberculosis is an etiological agent of tuberculosis. The …
humans worldwide. Mycobacterium tuberculosis is an etiological agent of tuberculosis. The …
Neutrophil‐plasmacytoid dendritic cell interaction leads to production of type I IFN in response to Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) can cause a latent infection that sometimes progresses to
clinically active tuberculosis (TB). Type I interferons (IFN‐I) have been implicated in initiating …
clinically active tuberculosis (TB). Type I interferons (IFN‐I) have been implicated in initiating …
Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death
AM Lee, CF Nathan - EMBO reports, 2024 - embopress.org
Abstract Type I interferons (IFN-I) are implicated in exacerbation of tuberculosis (TB), but the
mechanisms are unclear. Mouse macrophages infected with Mycobacterium tuberculosis …
mechanisms are unclear. Mouse macrophages infected with Mycobacterium tuberculosis …
Latent tuberculosis infection in Korean patients with multiple sclerosis and neuromyelitis optica spectrum disorder
KH Kim, SH Kim, NY Park, MJ Kim, JW Hyun… - Multiple Sclerosis and …, 2024 - Elsevier
Background Latent tuberculosis infection (LTBI) is defined as an immune response to
Mycobacterium tuberculosis infection that does not manifest clinically as active tuberculosis …
Mycobacterium tuberculosis infection that does not manifest clinically as active tuberculosis …
Acute disseminated encephalomyelitis in a young patient: A case report
RA Codreanu-Balaban… - Experimental and …, 2024 - spandidos-publications.com
The diagnosis of acute disseminated encephalomyelitis (ADEM) is challenging due to the
existence of other medical conditions that mimic its symptoms and the lack of precise …
existence of other medical conditions that mimic its symptoms and the lack of precise …
Back pain in rare diseases: A comparison of neck and back pain between spinal cord ischemia and spinal dural arteriovenous fistula
Neck and back pain may be noted like a first symptom in rare diseases: spinal cord ischemia
and spinal dural arteriovenous fistula (SDAVF). Spinal cord ischemia is a rarer pathology …
and spinal dural arteriovenous fistula (SDAVF). Spinal cord ischemia is a rarer pathology …
Lymphopenia and tuberculous lymphadenitis under immunomodulatory agents in a multiple sclerosis patient: Follow-up of a challenging case= Esetbemutatás …
FB Koseahmet, M Ozturk… - IDEGGYOGYASZATI …, 2022 - real.mtak.hu
Interferon-beta (IFN-β) 1a and glatiramer acetate (GA) are first-line therapies for multiple
sclerosis (MS) with immunomodulatory effects. We present a patient who developed …
sclerosis (MS) with immunomodulatory effects. We present a patient who developed …
Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: a systematic review
LA Dantas, MS Pereira, A de Miranda Gauza… - Multiple Sclerosis and …, 2021 - Elsevier
Background Tuberculosis (TB) is an infectious-contagious disease caused by
Mycobacterium tuberculosis. This disease can act acutely or in latent form as granuloma …
Mycobacterium tuberculosis. This disease can act acutely or in latent form as granuloma …
[HTML][HTML] A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report
A Miyasaka, S Sato, T Masuda… - The American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Reactivation of latent tuberculosis infection (LTBI) is a
recognized complication of immunosuppressive treatment. However, immunosuppressed …
recognized complication of immunosuppressive treatment. However, immunosuppressed …